Transfusion and Apheresis Science
Издатель: Elsevier · ISSN 1473-0502 · 69 статей
- FROM OBSERVATION TO INTEGRATION: STRENGTHENING UNDERGRADUATE TRANSFUSION MEDICINE EDUCATION THROUGH HORIZONTAL AND VERTICAL INTEGRATION
- Plerixafor in Poor Mobilizers: A Reliable Rescue Strategy for Hematopoietic Stem Cell Collection in patients with lymphoma
- DCE-MRI Muscle Perfusion Changes After Stem Cell Transplantation for Diabetic Lower Extremity Arterial Disease: Association With Clinical Ischemic Improvement
- Apheresis as a Continuum of Care: From Collection to Clinical Impact
- Editorial comment: From modern blood cell-derived bioproducts to tissue and organ engineering and hematopoietic stem cell therapy: Converging principles for cellular substitution and regenerative medicine
- Hematopoietic Stem Cell Mobilization outcomes following Rituximab ± ICE in Relapsed or Refractory Lymphomas
- Mobilization of Hematopoietic Stem Cells following Rituximab ± ESHAP in Relapsed or Refractory Lymphomas
- Pulmonary Dysfunction in Transfusion-Dependent β-Thalassemia: A Cross-Sectional Study of Iron Overload Assessed by Serum Ferritin and MRI T2*
- Optimizing Stem Cell Collection: Hematopoietic Stem Cell Mobilization Following GDP or GemOx-Based Salvage Therapy in Relapsed or Refractory Lymphoma
- Longitudinal Development and Operational Performance of an Integrated Clinical and Translational Research Platform in a Public Academic Cancer Center: A Retrospective Institutional Study
- Comparing umbilical cord blood platelet rich plasma and adult peripheral blood platelet rich plasma in burn wound healing
- Advancing Apheresis Practice Through Regional Collaboration: The DFW Apheresis Networking Group
- A Message from the WAA President
- Guest co-editor’s bio: Serdal Korkmaz
- Nursing implications in hematopoietic stem cell mobilization and apheresis
- Evaluation of hematopoietic stem cell mobilization following DHAP(C) ± rituximab in relapsed or refractory lymphomas
- Hematopoietic stem cell mobilization in relapsed or refractory lymphomas: A multi-center experience with BEGEV± rituximab
- Apheresis activities of the transplantation and cellular therapies society in Türkiye: Current practice, scientific contributions, and a roadmap for the cellular-therapy era
- Correlations between autograft cellular components and post-transplant outcome in patients with systemic non-Hodgkin lymphoma mobilized with on-demand plerixafor: A prospective multicenter GOA study
- Fondaparinux versus regional citrate anticoagulation in artificial liver support for patients with liver failure and high bleeding risk: A pilot randomized controlled trial
- Concurrent marked hypocalcemia and hypokalemia are associated with clinically significant citrate toxicity during peripheral blood stem cell collection
- Contemporary etiologies of crossmatch-incompatible red blood cell transfusions in non-emergent settings
- Efficacy of red blood cell transfusion relative to unit haemoglobin content in adult haematology-oncology patients
- JACIE accreditation: Evaluation at the STSH cell therapy unit
- Red blood cell alloimmunization in transfused oncology patients at a high-complexity center in Colombia
- Feasibility of collecting, processing and storing umbilical whole cord blood as a source for neonatal red blood cell transfusions (Whole-Cord)
- First report from the Marrakech-Safi region on red blood cell alloimmunization in sickle cell disease patients: Prevalence and associated factors
- Establishment of K562 cell lines expressing platelet antigen HPA-15 using lentiviral infection method
- “Development and preliminary biocompatibility evaluation of an BG-Ag-rGO/PCL-collagen dermal patch with in-vitro antimicrobial activity”
- Incidence and predictors of allergic transfusion reactions: A three-year retrospective cohort study with nested case-control analysis